The 28th Annual Meeting of The Photomedicine Society
The 28th Annual Meeting of The Photomedicine Society was held at:
February 28, 2019
Capitol Room
Marriott Marquis
901 Massachusetts Avenue NW
Washington, DC, USA
We are changing our name! To better reflect our mission, The Photomedicine Society will soon become The Society for Phototherapy and Photoprotection (SPP).
The planning committee is working hard to put together another innovative program.
| PROGRAM | ||
|---|---|---|
| 8:00 – 8:25 | Registration | |
| 8:25 – 8:30 | Opening Remarks Heidi Jacobe, MD, Dallas, Texas |
|
| New and Now: Innovations and Cutting Edge Research | ||
| 8:30 – 9:00 | Patrick J. Rochette, PhD, Quebec, Canada Chronic UVB Exposure Influence Genotoxic Stress Response in Skin Cells |
|
| 9:00 – 9:30 | Mary Sheu, MD, Baltimore, Maryland
Biomarkers Activated with Fractionated Laser |
|
| 9:30 – 10:00 | June K. Robinson, MD, Chicago, Illinois
Early Childhood Photoprotection Programs |
|
| 10:00 – 10:30 | Break/Poster Viewing | |
| 10:30 – 10:45 |
Abstract Presentation Tasneem F. Mohammad, MD, Detroit, Michigan The Effect of Combination Non‑steroidal Anti‑inflammatory Drugs and Phototherapy in Non‑Photoadapters with Vitiligo |
|
| 10:45 – 11:00 |
Abstract Presentation Breanne Mordorski, MD, Bronx, New York Curcumin Nanoparticles as a Photoprotective Adjuvant |
|
| 11:00 – 11:30 | Curtis Cole, PhD Photoallergy Safety Screening: Stuck in the Past? |
|
| 11:30 – 1:00 | Break for Lunch (lunch provided) | |
| Keynote Speakers FDA Panel Discussion | ||
| 1:00 – 1:15 | E. Dennis Bashaw, Pharm D Senior Science Advisor FDA The Maximal Usage Trial: Why MUsT it be Done? |
|
| 1:15 – 1:30 | Luke Oh, PhD Senior Staff Fellow FDA Sunscreen in your System: Generally Recognized as Safe? |
|
| 1:30 – 1:45 | Sojeong Yi, PhD Clinical Pharmacology Reviewer FDA In Vitro Skin Permeation Test Coupled with MUsT to Evaluate Dermal Absorption of Sunscreens |
|
| 1:45 – 2:00 | Q & A | |
| 2:00 – 2:15 | Break | |
| CONCURRENT SESSIONS | ||
| Phototherapy A-Z: A Practical Course for the Dermatology Provider Capitol Room |
||
| 2:15 – 3:15 | Elisabeth Richard, MD, Baltimore, Maryland Part 1: PUVA: Clinical Pearls and Practical Matters Discussion Part 2: Primer for Phototesting and Photosensitivity |
|
| 3:15 – 3:30 | Break | |
| 3:30 – 4:00 | Kristen M. Beck, MD, San Francisco, California Phototherapy of Checkpoint Inhibitor Dermatoses |
|
| 4:00 – 4:30 | Noori Kim, MD, Baltimore, Maryland Narrow Band UVB Phototherapy for Uremic Pruritus |
|
| Photoprotection Workshop Congress Room |
||
| 2:30 – 2:50 | J. Frank Nash, PhD, Mason, Ohio Toxicological Risk Assessment of UV Filters/Sunscreen Products: Current Considerations |
|
| 2:50 – 3:10 | Henry W. Lim, MD, Detroit, Michigan Environmental Impact of UV Filters: How Should We Advise our Patients? |
|
| 3:10 – 3:30 | Eduardo Ruvolo, MS, Whippany, New Jersey New Learning in Photoprotection |
|
| 3:30 – 3:45 | Break | |
| 3:45 – 4:05 | Brian Underwood, BA, New York, New York Impact of Media on Sun Protection |
|
| 4:05 – 4:25 | Shaun Hughes, MBA, Seattle, Washington Curtis Cole, PhD, Ringoes, New Jersey SPF, Broad Spectrum and Action Spectrum Testing in Natural Sunlight |
|
| 4:25 – 4:45 |
Uli Osterwalder, MS, Basel, Switzerland Alternative SPF Methods – Where Do We Stand? |
|
Continuing Medical Education Credit will not be available for this year’s meeting.